JPS5813525B2 - anticoccidial agent - Google Patents
anticoccidial agentInfo
- Publication number
- JPS5813525B2 JPS5813525B2 JP49147908A JP14790874A JPS5813525B2 JP S5813525 B2 JPS5813525 B2 JP S5813525B2 JP 49147908 A JP49147908 A JP 49147908A JP 14790874 A JP14790874 A JP 14790874A JP S5813525 B2 JPS5813525 B2 JP S5813525B2
- Authority
- JP
- Japan
- Prior art keywords
- test
- acid
- infection
- anticoccidial
- chicks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940124536 anticoccidial agent Drugs 0.000 title claims description 10
- 239000003224 coccidiostatic agent Substances 0.000 title claims description 10
- XPPIIYHZGYTOTA-UHFFFAOYSA-N 2-nitropyridine-4-carboxamide Chemical compound NC(=O)C1=CC=NC([N+]([O-])=O)=C1 XPPIIYHZGYTOTA-UHFFFAOYSA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 210000003250 oocyst Anatomy 0.000 description 8
- 208000003495 Coccidiosis Diseases 0.000 description 7
- 206010023076 Isosporiasis Diseases 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 241000223924 Eimeria Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 244000144977 poultry Species 0.000 description 5
- 235000013594 poultry meat Nutrition 0.000 description 5
- 241000224483 Coccidia Species 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- ZDPIZLCVJAAHHR-UHFFFAOYSA-N Clopidol Chemical compound CC1=NC(C)=C(Cl)C(O)=C1Cl ZDPIZLCVJAAHHR-UHFFFAOYSA-N 0.000 description 2
- 241000223932 Eimeria tenella Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- -1 inorganic acid salts Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 150000003248 quinolines Chemical class 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 description 1
- GMUFGAIZRAMTEN-UHFFFAOYSA-N 5-(hydroxymethyl)-2-methylpyridin-3-ol Chemical compound CC1=NC=C(CO)C=C1O GMUFGAIZRAMTEN-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 229940123414 Folate antagonist Drugs 0.000 description 1
- 241000567229 Isospora Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930191564 Monensin Natural products 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960003683 amprolium Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003432 anti-folate effect Effects 0.000 description 1
- 230000000842 anti-protozoal effect Effects 0.000 description 1
- 230000002133 anti-thiamin Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940127074 antifolate Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 229940027988 antiseptic and disinfectant nitrofuran derivative Drugs 0.000 description 1
- 150000001495 arsenic compounds Chemical class 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229950003639 buquinolate Drugs 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 229960000731 clopidol Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- JHAYEQICABJSTP-UHFFFAOYSA-N decoquinate Chemical compound N1C=C(C(=O)OCC)C(=O)C2=C1C=C(OCC)C(OCCCCCCCCCC)=C2 JHAYEQICABJSTP-UHFFFAOYSA-N 0.000 description 1
- 229960001878 decoquinate Drugs 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 229940096118 ella Drugs 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- LVVXOXRUTDAKFE-UHFFFAOYSA-N ethyl 6,7-bis(2-methylpropoxy)-4-oxo-1h-quinoline-3-carboxylate Chemical compound CC(C)COC1=C(OCC(C)C)C=C2C(=O)C(C(=O)OCC)=CNC2=C1 LVVXOXRUTDAKFE-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000004052 folic acid antagonist Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 229940093920 gynecological arsenic compound Drugs 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- PJBQYZZKGNOKNJ-UHFFFAOYSA-M hydron;5-[(2-methylpyridin-1-ium-1-yl)methyl]-2-propylpyrimidin-4-amine;dichloride Chemical compound Cl.[Cl-].NC1=NC(CCC)=NC=C1C[N+]1=CC=CC=C1C PJBQYZZKGNOKNJ-UHFFFAOYSA-M 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- FSBDZOPIXYRGJO-UHFFFAOYSA-N methyl 2-nitropyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC([N+]([O-])=O)=C1 FSBDZOPIXYRGJO-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005358 monensin Drugs 0.000 description 1
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
- YZMHQCWXYHARLS-UHFFFAOYSA-N naphthalene-1,2-disulfonic acid Chemical class C1=CC=CC2=C(S(O)(=O)=O)C(S(=O)(=O)O)=CC=C21 YZMHQCWXYHARLS-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical class NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 1
- 229960000611 pyrimethamine Drugs 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004215 spore Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 1
- 229960000973 sulfadimethoxine Drugs 0.000 description 1
- 229960003097 sulfaquinoxaline Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は式
で示される4−カルバモイル−2−ニトロピリジンまた
はその酸付加塩を有効成分とする動物用抗コクシジウム
剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an anticoccidial agent for animals containing 4-carbamoyl-2-nitropyridine represented by the formula or an acid addition salt thereof as an active ingredient.
酸付加塩としては有機酸あるいは無機酸の塩、例えば塩
酸、硫酸、硝酸、シュウ酸、マレイン酸、酒石酸、マロ
ン酸、クエン酸、フタール酸、ナフタリンジスルホン酸
の塩等の製薬的非毒性塩があげられる。Acid addition salts include pharmaceutical non-toxic salts of organic or inorganic acids, such as hydrochloric acid, sulfuric acid, nitric acid, oxalic acid, maleic acid, tartaric acid, malonic acid, citric acid, phthalic acid, naphthalene disulfonic acid salts, etc. can give.
コクシジウム症(Coccidisis)は原生動物の
胞子中網(Sporozoa)のコクシジア(Coc−
cidia球虫目)に属する寄生性原虫症であり、家禽
および家畜の消火器病および栄養障害を起こし斃死をも
たらす伝染病であって、鶏に最も多発し、家兎、山羊、
緬羊、牛、あひる、うずら、七面鳥などにも被害を及ぼ
し、養禽、家畜業に多大な損害を与えている。Coccidiosis is a disease caused by coccidia of the protozoan Sporozoa.
It is a parasitic protozoan disease belonging to the order Coccidiformes (order), and is an infectious disease that causes fire extinguisher diseases and malnutrition in poultry and livestock, causing death.It is most common in chickens, but it is most common in domestic rabbits, goats,
It also damages sheep, cattle, ducks, quail, and turkeys, causing great damage to the poultry and livestock industries.
コクシジアのアイメリア科(Eimeridae)には
アイメリア(Eimeria)およびイソスポラ(Is
ospora)なと10数種の属があるが家禽および家
畜のコクシジウム症はアイメリア属によって発症するこ
とが多い。The family Eimeridae of coccidia includes Eimeria and Isospora.
There are more than 10 genera such as Eimeria (Eimeria), but coccidiosis in poultry and livestock is often caused by the genus Eimeria.
コクシジウムのオーシスト(Occyst、原母細胞)
は糞便と共に排泄され、適当な条件下で24〜48時間
後に胞子形成を行ない感染力を有するようになって、経
口的に感染する。Coccidian oocyst (Occyst, protocyte)
is excreted with feces, and under appropriate conditions, after 24 to 48 hours, it forms spores, becomes infectious, and infects orally.
オーシストは宿主の盲腸または小腸の粘膜細胞内で最初
は無性生殖を行なって繁殖し、この間に最も重い症状を
発現し、ついで有性生殖を行なってオーシストを形成し
、糞便と共に排泄されることにより恐るべき伝染性を発
揮する。Oocysts initially reproduce asexually within the mucosal cells of the host's cecum or small intestine, during which time they develop the most severe symptoms, and then sexually reproduce to form oocysts, which are excreted with feces. This makes it extremely contagious.
このような家禽および家畜のコクシジウム症に対して従
来多くの化学療法剤による予防治療法が提案され、特に
コクシジウム症に対する予防治療剤として、例えばサル
ファ剤、砒素化合物、ニトロフラン誘導体、ニトロフエ
ナイド、ナイカルパジン、ピリミジン誘導体(抗チアミ
ン剤)、キノリン誘導体、グアニジン誘導体、抗生物質
などが紹介されたが、薬効、抗原虫スペクトル、対象動
物に対する安全性あるいは薬剤耐性が出来易いなどそれ
ぞれ欠点をもち満足すべき薬剤とはいえない。Many preventive treatments using chemotherapeutic agents have been proposed for such coccidiosis in poultry and domestic animals. In particular, as preventive treatments for coccidiosis, for example, sulfa drugs, arsenic compounds, nitrofuran derivatives, nitrophenides, nicarpazin, pyrimidine, etc. Derivatives (antithiamine drugs), quinoline derivatives, guanidine derivatives, antibiotics, etc. have been introduced, but each has its own drawbacks such as efficacy, antiprotozoal spectrum, safety for target animals, and ease of developing drug resistance, so it is unclear which drugs are satisfactory. I can't say that.
本発明のコクシジウム症予防治療剤はアイメリア属全般
に効果を有するものであり、特に最も病原性の強い盲腸
寄生のアイメリア・テネラ(Ei−meria Ten
ella)に対して著効を示す。The preventive and therapeutic agent for coccidiosis of the present invention is effective against the entire genus Eimeria, and is particularly effective against Ei-meria tenella, the most pathogenic cecal parasite.
ella).
さらに本発明における有効成分は現在広く用いられてい
るチアミン系抗コクシジウム剤の耐性株にも著効を示す
。Furthermore, the active ingredient of the present invention is highly effective against strains resistant to thiamine-based anticoccidial agents that are currently widely used.
本発明で使用する4−カルバモイル−2−ニトロピリジ
ンは新規化合物であり、次式に示すように、化合物(■
)〔オーストラリアン・ジャーナル・オブ・ケミストリ
ー(Aue.J.Chem) 2 4巻、377ページ
(1971年)記載〕をアンモニア水と接触させて得る
か、または化合物(■)〔ジャーナル・オプ・ザ・アメ
リカン・ケミカル・ソサイエテイ(J.Am.Chem
.Soc.)7 6巻、3167ページ(1954年)
記載〕を塩化チオニルと反応させて酸クロライドとした
後、アンモニアと接触させて得るか、あるいは化合物(
■)をクロロホーメート(Rはアルキル基)ベンジル基
またはフユニル基を示す)と反応させて酸無水物とした
後、アンモニアと接触させて得ることができる。4-Carbamoyl-2-nitropyridine used in the present invention is a new compound, and as shown in the following formula, the compound (■
) [described in Australian Journal of Chemistry, Vol. 2, 4, p.・American Chemical Society (J.Am.Chem)
.. Soc. )7 Volume 6, page 3167 (1954)
[description] with thionyl chloride to form an acid chloride, and then contacting it with ammonia, or the compound (
(2)) is reacted with a chloroformate (R is an alkyl group, benzyl group or fuunyl group) to form an acid anhydride, and then the acid anhydride is brought into contact with ammonia.
反応後は常法により目的物を得る。After the reaction, the desired product is obtained by a conventional method.
例えば反応後結晶を濾過、再結晶を行い所望の目的物を
得る。For example, after the reaction, the crystals are filtered and recrystallized to obtain the desired target product.
次に参考例を示して上記方法をさらに具体的に説明する
。Next, the above method will be explained in more detail by referring to a reference example.
参考例
4−メトキシカルボニル−2−ニトロピリジン400m
gを28%アンモニア水2mlと室温下1時間攪拌する
。Reference example 4-methoxycarbonyl-2-nitropyridine 400m
Stir g with 2 ml of 28% aqueous ammonia at room temperature for 1 hour.
溶媒を留去後エタノール−エーテルより再結晶を行うと
所望の目的物348mgを得た。After distilling off the solvent, recrystallization was performed from ethanol-ether to obtain 348 mg of the desired target product.
融点(分解)173℃
元素分析値 C6H5N303として
計算値:C,43.12;H.3.02;N.25.1
5実験値:C,43.17;H.3.05;N,25.
04本発明を実施するには、4−カルバモイル−2−ニ
トロピリジンまたはその有機酸塩もしくは無機酸塩を必
要に応じて生理的に無害な担体と配合して用いられる。Melting point (decomposition) 173°C Elemental analysis value Calculated value as C6H5N303: C, 43.12; 3.02;N. 25.1
5 Experimental value: C, 43.17; H. 3.05; N, 25.
04 In carrying out the present invention, 4-carbamoyl-2-nitropyridine or its organic or inorganic acid salts are used in combination with a physiologically harmless carrier, if necessary.
通常は動物用飼料に配合、または飲料水に分散もしくは
溶解して用いられる。It is usually added to animal feed or dispersed or dissolved in drinking water.
動物用飼料としては例えば穀粉、外皮、醗酵残留物、粕
類、糠類があげられる。Examples of animal feed include flour, hulls, fermentation residues, lees, and bran.
この試料には粉砕した石灰石、タルク末などを混合して
もよく、混合は粉砕、攪拌、転磨のような方法によって
固体または半固体に製造する。This sample may be mixed with crushed limestone, talc powder, etc., and the mixture is made into a solid or semi-solid by methods such as crushing, stirring, and rolling.
本発明の上記調製物には他の抗コクシジウム剤例えばサ
ルファタロルピラジン、スルファジメトキシン、スルフ
ァキノキサリンのようなサルファ剤;あるいはチアミン
誘導体例えばペクロチアミン、アンプロリウム、ジメチ
アリウム;キノリン誘導体例えばブキノレート、デコキ
ネート、メチルベンゾクウエート:葉酸拮抗物質例えば
ピリメタミン、ジアペリジン:抗性物質例えばモネンシ
ン;あるいはその他の抗コクシジウム剤例えば3−ヒド
ロキシ−5−ヒドロキシメチル−2−メチルピリジン、
クロピドール(3,5−ジクロルー2.6−ジメチル−
4−ピリジノール)、ロベンジデンなどを含有せしめて
もよい。The above preparations of the invention may contain other anticoccidial agents such as sulfa drugs such as sulfatalorpyrazine, sulfadimethoxine, sulfaquinoxaline; or thiamine derivatives such as pecrothiamine, amprolium, dimethiarium; quinoline derivatives such as buquinolate, decoquinate, methylbenzokuwait: Folate antagonists such as pyrimethamine, diaperidine; antifolates such as monensin; or other anticoccidial agents such as 3-hydroxy-5-hydroxymethyl-2-methylpyridine;
Clopidol (3,5-dichloro-2,6-dimethyl-
4-pyridinol), lobenzidene, and the like.
本発明の抗コクシジウム剤の投与濃度は家禽および家畜
の種類、投与方法、投与目的、症状等によって一概には
いえないが、例えば飼料添加して予防する場合は25〜
250ppmで用いられ、治療には500〜1000p
pmで使用される。The dosage concentration of the anticoccidial agent of the present invention cannot be determined unconditionally depending on the type of poultry or livestock, administration method, administration purpose, symptoms, etc., but for example, when preventing by adding it to feed,
Used at 250ppm, 500-1000p for treatment
Used in pm.
次に本発明の抗コクシジウム剤の効果を示す試験例をあ
げる。Next, a test example showing the effect of the anti-coccidiosis agent of the present invention will be given.
試験例
供試材料および試験方法
1)供試ヒナ:単冠白色レグホン種、雄ヒナ、実験開始
14日令(ふ化後直ちに初生ヒナを試験開始まで抗コク
シジウム剤を含有しない幼雛用配合飼料を給与して隔離
飼育した。Test Example Test Materials and Test Methods 1) Test chicks: single crowned white leghorn, male chicks, 14 days old from the start of the experiment (immediately after hatching, day-old chicks were fed a compound feed for young chicks that did not contain an anticoccidial agent until the start of the test) They were fed and kept in isolation.
)2)供試コクシジウム:アイメリア・テネラ(Eim
eria tenella)の胞子形成オーシストを1
羽当り42.000個ずつ直接そのう内に経口接種して
感染させた。)2) Test coccidium: Eimeria tenella (Eim
eria tenella) sporulating oocysts.
Infection was carried out by orally inoculating 42,000 eggs per wing directly into the pouch.
3)供試薬剤:4−カルバモイル−2−ニトロピリジン
4)供試薬剤の飼料への添加濃度:抗コクシジウム剤を
含有しない市販の幼雛用配合飼料に供試薬剤を200p
pm混合した。3) Test drug: 4-carbamoyl-2-nitropyridine 4) Concentration of test drug added to feed: Add 200p of test drug to commercially available compound feed for young chicks that does not contain anticoccidial agent.
pm was mixed.
5)試験方法:上記供試ヒナをコクシジウム症鶏から隔
離飼育し、健康状態を観察し、正常なヒナについて体重
を測定し、各区の平均体重に有意差(危険率5%水準)
のないように10羽/区ずつに区分けした。5) Test method: The above test chicks were raised in isolation from coccidiosis chickens, their health conditions were observed, and the weights of normal chicks were measured. There was a significant difference in the average weight of each group (risk level 5% level).
The birds were divided into 10 birds/area to avoid any confusion.
さらに感染無投薬対照および無投薬無感染対照の2群を
設けた。Furthermore, two groups were established: an infection-free control and a no-medication and infection-free control.
区分け後無感染無投薬対照区を除く全区にオーシストの
一定数を接種し、同時に供試薬剤を含有する飼料を給与
し、対照の2つの区には供試薬剤を添加しない同一組成
(同一ロット)の飼料を維与した。After division, a certain number of oocysts were inoculated in all plots except for the uninfected and unmedicated control plot, and feed containing the test drug was fed at the same time. Lot) feed was maintained.
6)判定:試験開始時(投薬および感染時)から終了時
(感染後7日)まで一定時刻に体重を測定し、感染後6
〜7日までに排泄された糞中のオーシスト数を毎日測定
した。6) Judgment: Body weight was measured at fixed times from the start of the test (at the time of administration and infection) to the end (7 days after infection).
The number of oocysts in excreted feces was measured every day up to 7 days.
感染後7日目に全生存ヒナを剖検し、コクシジウムによ
る盲腸の病変の程度をエキスペリメンタル・パラシトロ
ジー(Exptl.Parasit.)第28巻30〜
36ページ(1970年)記載のジョンソン・アンド・
リード(Johnson and Reid)の方法に
より0〜4の5段階法により判定した。All surviving chicks were necropsied on the 7th day after infection, and the degree of cecal lesions caused by coccidia was determined using Experimental Parasitology (Exptl. Parasit.) Vol. 28, 30-
Johnson & Co. on page 36 (1970)
Judgment was made using a 5-step scale from 0 to 4 according to the method of Johnson and Reid.
試験開始時から終了時までの体重増加量を増体量とし、
各試験区の羽数で除したものを平均増体量とした。The amount of weight gain from the start of the test to the end of the test is defined as the amount of weight gain.
The average weight gain was divided by the number of birds in each test plot.
感染後6日および7日に排泄された糞1g中のオーシス
ト数を各試験区ごとに加算してオーシスト数とした。The number of oocysts in 1 g of feces excreted on the 6th and 7th days after infection was added for each test section to determine the number of oocysts.
試験結果 表1に示す。Test results It is shown in Table 1.
本発明の抗コクシジウム剤は感染無投薬対照区に比べて
著効を有することが認められる。The anti-coccidial agent of the present invention was found to be more effective than the control group without infection.
また副作用もみられなかった。薬剤を投与する場合は、
コクシジナの各発育期のうちで第一無性生殖期、および
第二無性生殖期が最も有効である。Also, no side effects were observed. When administering drugs,
Among the developmental stages of Coccidina, the first asexual reproductive stage and the second asexual reproductive stage are the most effective.
Claims (1)
酸付加塩を有効成分とする抗コクシジウム剤。1. An anticoccidial agent containing 4-carbamoyl-2-nitropyridine or an acid addition salt thereof as an active ingredient.
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49147908A JPS5813525B2 (en) | 1974-12-23 | 1974-12-23 | anticoccidial agent |
| US05/639,697 US4054663A (en) | 1974-12-23 | 1975-12-11 | Pyridine derivatives and their use as anticoccidial agents |
| GB51406/75A GB1506950A (en) | 1974-12-23 | 1975-12-16 | Pyridine derivatives and their use as anticoccidial agent |
| CA242,303A CA1067901A (en) | 1974-12-23 | 1975-12-22 | Carbamoyl nitro pyridine compounds |
| BR7508535*A BR7508535A (en) | 1974-12-23 | 1975-12-22 | PROCESS TO PREPARE PYRIDINE DERIVATIVES AND ANTICOCCIDIAL COMPOSITES |
| DE19752558278 DE2558278A1 (en) | 1974-12-23 | 1975-12-23 | PYRIDINE DERIVATIVES AND THEIR USE AS AN AGENT AGAINST COCCIDIOSIS |
| FR7539440A FR2295748A1 (en) | 1974-12-23 | 1975-12-23 | NEW PYRIDINE DERIVATIVES AND THEIR APPLICATIONS |
| IT70177/75A IT1052734B (en) | 1974-12-23 | 1975-12-23 | PYRIDINE DERIVATIVES USEFUL TO COMBAT COCCIDIOSIS |
| AU87800/75A AU498956B2 (en) | 1974-12-23 | 1975-12-23 | Pyridine derivatives & their use as anticoccidial agents |
| NZ179646A NZ179646A (en) | 1974-12-23 | 1975-12-23 | 2-or 6-nitropyridinecarbo xamide derivatives and anticoccidial compositions |
| US05/816,215 US4098893A (en) | 1974-12-23 | 1977-07-15 | Pyridine derivatives and their use as anticoccidial agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49147908A JPS5813525B2 (en) | 1974-12-23 | 1974-12-23 | anticoccidial agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5176439A JPS5176439A (en) | 1976-07-02 |
| JPS5813525B2 true JPS5813525B2 (en) | 1983-03-14 |
Family
ID=15440831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49147908A Expired JPS5813525B2 (en) | 1974-12-23 | 1974-12-23 | anticoccidial agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5813525B2 (en) |
-
1974
- 1974-12-23 JP JP49147908A patent/JPS5813525B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5176439A (en) | 1976-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08231410A (en) | Coccidiosis-reducing agent and feed containing the same | |
| JP2002532545A (en) | Triazine-on compounds for the treatment of diseases caused by carcinospores, precocious sporeworms and toxoplasma | |
| JPS5874607A (en) | Anticoccidial composition | |
| US6569843B1 (en) | Steroidal sapogenins for the control of coccidiosis in animals | |
| US3215597A (en) | Methods and compositions for use in animal husbandry | |
| US3206358A (en) | Pyridinols employed in animal husbandry | |
| US3271249A (en) | Dihalobenzimidazoles for poultry disease treatment | |
| KR20010080571A (en) | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma | |
| JPS5813525B2 (en) | anticoccidial agent | |
| JP2001089379A (en) | Treatment or prevention of coccidiosis | |
| Schildknecht et al. | Antiparasitic activity of natural and semisynthetic monensin urethanes | |
| EP0086774A1 (en) | Treatment of coccidial infections with amidinourea or amidinothiourea derivatives | |
| CH651206A5 (en) | VETERINAER MEDICINES FOR PROPHYLAXIS OR TREATMENT OF PROTOZOE INFECTIONS. | |
| US3518305A (en) | Nitro-trifluoromethylbenzamides | |
| JPS5817444B2 (en) | anticoccidial agent | |
| US4015016A (en) | [(2-Alkoxyberzylidine)amino]quanidines and their anticoccidal use | |
| US4764534A (en) | Anticoccidial naphthalenamines and combinations thereof | |
| US2877154A (en) | Anthelmintic compositions containing chlorine substituted amides and methods for using same | |
| JPS5840531B2 (en) | anticoccidial agent | |
| US3928437A (en) | Phenoxy-phenyl, phenylthiophenyl, phenylsulfonylphenyl and phenylaminophenyl diaminothioureas | |
| JPS5951524B2 (en) | anticoccidial agent | |
| US4079069A (en) | 5-Deazariboflavin and its derivatives | |
| US3555085A (en) | Nitro-trifluoromethylthiobenzamides | |
| JPS5951535B2 (en) | 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient | |
| US3655887A (en) | Compositions for treatment of toxoplasmosis and coccidiosis |